Abstract
9036Background: Treatment options are limited in pts who progress on anti-PD-(L)1 therapy. HDAC inhibitors have the potential to modulate myeloid-derived suppressor cell (MDSC) function and may syn...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
